Searched for: in-biosketch:yes
person:adhiks04
Prevalence and Outcomes of D-Dimer Elevation in Hospitalized Patients With COVID-19
Berger, Jeffrey S; Kunichoff, Dennis; Adhikari, Samrachana; Ahuja, Tania; Amoroso, Nancy; Aphinyanaphongs, Yindalon; Cao, Meng; Goldenberg, Ronald; Hindenburg, Alexander; Horowitz, James; Parnia, Sam; Petrilli, Christopher; Reynolds, Harmony; Simon, Emma; Slater, James; Yaghi, Shadi; Yuriditsky, Eugene; Hochman, Judith; Horwitz, Leora I
OBJECTIVE:<0.001). Rates of adverse events increased with the magnitude of D-dimer elevation; individuals with presenting D-dimer >2000 ng/mL had the highest risk of critical illness (66%), thrombotic event (37.8%), acute kidney injury (58.3%), and death (47%). CONCLUSIONS:Abnormal D-dimer was frequently observed at admission with COVID-19 and was associated with higher incidence of critical illness, thrombotic events, acute kidney injury, and death. The optimal management of patients with elevated D-dimer in COVID-19 requires further study.
PMID: 32840379
ISSN: 1524-4636
CID: 4574192
More on Covid-19 in Immune-Mediated Inflammatory Diseases. Reply [Comment]
Haberman, Rebecca H; Adhikari, Samrachana; Scher, Jose U
PMID: 32649071
ISSN: 1533-4406
CID: 4580992
Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York [Letter]
Haberman, Rebecca; Axelrad, Jordan; Chen, Alan; Castillo, Rochelle; Yan, Di; Izmirly, Peter; Neimann, Andrea; Adhikari, Samrachana; Hudesman, David; Scher, Jose U
PMCID:7204427
PMID: 32348641
ISSN: 1533-4406
CID: 4438562
Assessment of Community-Level Disparities in Coronavirus Disease 2019 (COVID-19) Infections and Deaths in Large US Metropolitan Areas
Adhikari, Samrachana; Pantaleo, Nicholas P; Feldman, Justin M; Ogedegbe, Olugbenga; Thorpe, Lorna; Troxel, Andrea B
PMCID:7388025
PMID: 32721027
ISSN: 2574-3805
CID: 4574042
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19
Reynolds, Harmony R; Adhikari, Samrachana; Pulgarin, Claudia; Troxel, Andrea B; Iturrate, Eduardo; Johnson, Stephen B; Hausvater, Anaïs; Newman, Jonathan D; Berger, Jeffrey S; Bangalore, Sripal; Katz, Stuart D; Fishman, Glenn I; Kunichoff, Dennis; Chen, Yu; Ogedegbe, Gbenga; Hochman, Judith S
BACKGROUND:There is concern about the potential of an increased risk related to medications that act on the renin-angiotensin-aldosterone system in patients exposed to coronavirus disease 2019 (Covid-19), because the viral receptor is angiotensin-converting enzyme 2 (ACE2). METHODS:We assessed the relation between previous treatment with ACE inhibitors, angiotensin-receptor blockers, beta-blockers, calcium-channel blockers, or thiazide diuretics and the likelihood of a positive or negative result on Covid-19 testing as well as the likelihood of severe illness (defined as intensive care, mechanical ventilation, or death) among patients who tested positive. Using Bayesian methods, we compared outcomes in patients who had been treated with these medications and in untreated patients, overall and in those with hypertension, after propensity-score matching for receipt of each medication class. A difference of at least 10 percentage points was prespecified as a substantial difference. RESULTS:Among 12,594 patients who were tested for Covid-19, a total of 5894 (46.8%) were positive; 1002 of these patients (17.0%) had severe illness. A history of hypertension was present in 4357 patients (34.6%), among whom 2573 (59.1%) had a positive test; 634 of these patients (24.6%) had severe illness. There was no association between any single medication class and an increased likelihood of a positive test. None of the medications examined was associated with a substantial increase in the risk of severe illness among patients who tested positive. CONCLUSIONS:We found no substantial increase in the likelihood of a positive test for Covid-19 or in the risk of severe Covid-19 among patients who tested positive in association with five common classes of antihypertensive medications.
PMID: 32356628
ISSN: 1533-4406
CID: 4412912
A Latent Space Network Model for Social Influence
Sweet, Tracy; Adhikari, Samrachana
Social network data represent interactions and relationships among groups of individuals. One aspect of social interaction is social influence, the idea that beliefs or behaviors change as a result of one's social network. The purpose of this article is to introduce a new model for social influence, the latent space model for influence, which employs latent space positions so that individuals are affected most by those who are "closest" to them in the latent space. We describe this model along with some of the contexts in which it can be used and explore the operating characteristics using a series of simulation studies. We conclude with an example of teacher advice-seeking networks to show that changes in beliefs about teaching mathematics may be attributed to network influence.
PMID: 32221792
ISSN: 1860-0980
CID: 4368602
Sex Differences in Myocardial Injury and Outcomes of Covid-19 Infection [Meeting Abstract]
Talmor, Nina; Mukhopadhyay, Amrita; Xia, Yuhe; Adhikari, Samrachana; Pulgarin, Claudia; Iturrate, Eduardo; Horwitz, Leora I.; Hochman, Judith S.; Berger, Jeffrey S.; Fishman, Glenn I.; Troxel, Andrea B.; Reynolds, Harmony
ISI:000607190404381
ISSN: 0009-7322
CID: 5263742
A Pilot Randomized Controlled Study of a Smartphone Delivered Progressive Muscle Relaxation Intervention for Migraine in Primary Care [Meeting Abstract]
Minen, Mia; Adhikari, Samrachana; Padikkala, Jane; Goldberg, Eric; Powers, Scott; Tasneem, Sumaiya; Bagheri, Ashley; Lipton, Richard
ISI:000536058001007
ISSN: 0028-3878
CID: 4561062
Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress: treated cases versus propensity-matched controls
Gorenstein, Scott A; Castellano, Michael L; Slone, Eric S; Gillette, Brian; Liu, Helen; Alsamarraie, Cindy; Jacobson, Alan M; Wall, Stephen P; Adhikari, Samrachana; Swartz, Jordan L; McMullen, Jenica J S; Osorio, Marcela; Koziatek, Christian A; Lee, David C
Objective/UNASSIGNED:Given the high mortality and prolonged duration of mechanical ventilation of COVID-19 patients, we evaluated the safety and efficacy of hyperbaric oxygen for COVID-19 patients with respiratory distress. Methods/UNASSIGNED:This is a single-center clinical trial of COVID-19 patients at NYU Winthrop Hospital from March 31 to April 28, 2020. Patients in this trial received hyperbaric oxygen therapy at 2.0 atmospheres of pressure in monoplace hyperbaric chambers for 90 minutes daily for a maximum of five total treatments. Controls were identified using propensity score matching among COVID-19 patients admitted during the same time period. Using competing-risks survival regression, we analyzed our primary outcome of inpatient mortality and secondary outcome of mechanical ventilation. Results/UNASSIGNED:We treated 20 COVID-19 patients with hyperbaric oxygen. Ages ranged from 30 to 79 years with an oxygen requirement ranging from 2 to 15 liters on hospital days 0 to 14. Of these 20 patients, two (10%) were intubated and died, and none remain hospitalized. Among 60 propensity-matched controls based on age, sex, body mass index, coronary artery disease, troponin, D-dimer, hospital day, and oxygen requirement, 18 (30%) were intubated, 13 (22%) have died, and three (5%) remain hospitalized (with one still requiring mechanical ventilation). Assuming no further deaths among controls, we estimate that the adjusted subdistribution hazard ratios were 0.37 for inpatient mortality (p=0.14) and 0.26 for mechanical ventilation (p=0.046). Conclusion/UNASSIGNED:Though limited by its study design, our results demonstrate the safety of hyperbaric oxygen among COVID-19 patients and strongly suggests the need for a well-designed, multicenter randomized control trial.
PMID: 32931666
ISSN: 1066-2936
CID: 4591182
Nonparametric Bayesian Instrumental Variable Analysis: Evaluating Heterogeneous Effects of Coronary Arterial Access Site Strategies
Adhikari, Samrachana; Rose, Sherri; Normand, Sharon-Lise
Percutaneous coronary interventions (PCIs) are nonsurgical procedures to open blocked blood vessels to the heart, frequently using a catheter to place a stent. The catheter can be inserted into the blood vessels using an artery in the groin or an artery in the wrist. Because clinical trials have indicated that access via the wrist may result in fewer post procedure complications, shortening the length of stay, and ultimately cost less than groin access, adoption of access via the wrist has been encouraged. However, patients treated in usual care are likely to differ from those participating in clinical trials, and there is reason to believe that the effectiveness of wrist access may differ between males and females. Moreover, the choice of artery access strategy is likely to be influenced by patient or physician unmeasured factors. To study the effectiveness of the two artery access site strategies on hospitalization charges, we use data from a state-mandated clinical registry including 7,963 patients undergoing PCI. A hierarchical Bayesian likelihood-based instrumental variable analysis under a latent index modeling framework is introduced to jointly model outcomes and treatment status. Our approach accounts for unobserved heterogeneity via a latent factor structure, and permits nonparametric error distributions with Dirichlet process mixture models. Our results demonstrate that artery access in the wrist reduces hospitalization charges compared to access in the groin, with a higher mean reduction for male patients.
PMCID:7872102
PMID: 33568877
ISSN: 0162-1459
CID: 5018252